|
|
Article: Kendle Appoints J. Michael Sprafka, MPH, PhD, Vice President, Kendle Consulting.
- Article from:
- Biotech Week
- Article date:
- November 18, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Kendle (NASDAQ:KNDL), a leading, global full-service clinical research organization, announced the appointment of J. Michael Sprafka, MPH, PhD, as Vice President, Kendle Consulting. Dr. Sprafka will provide leadership for and drive the development of integrated product development consulting services to help biopharmaceutical companies accelerate time to market and maximize the long-term commercial value of their products. His focus will be on delivery of best-in-class consulting services for customers in the areas of regulatory affairs and submissions, risk management, epidemiology, pharmacovigilance, signal detection and safety evaluations, among others. Dr. Sprafka has ...
Related newspaper, magazine, and journal articles:
|
|
Article: Vice President Takes Health Care Message to ...
U.S. Newswire;
October 5, 1993 ;
672 words
... ... care plan will be the focus of the Vice President's visits to San Francisco and Venice ... California, on Monday, September 27. The Vice President will visit with senior citizens Monday ... PRESS. Also on Monday (9/27), the Vice President will tour a health care clinic in Venice ...
|
|